1. FRI0488 A Phase Iii Pivotal Umbrella Trial of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes (Colchicine Resistant FMF, HIDS/MKD and TRAPS). (15th July 2016) Authors: De Benedetti, F.; Anton, J.; Gattorno, M.; Lachmann, H.; Kone-Paut, I.; Ozen, S.; Frenkel, J.; Simon, A.; Zeft, A.; Ben-Chetrit, E.; Hoffman, H.; Joubert, Y.; Lheritier, K.; Speziale, A.; Junge, G. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0489 Canakinumab Improves Patient Reported Outcomes in Patients with Periodic Fever Syndromes. (15th July 2016) Authors: Lachmann, H.; Simon, A.; Anton, J.; Gattorno, M.; Kone-Paut, I.; Ozen, S.; Frenkel, J.; Ben-Chetrit, E.; Hoffman, H.; Zeft, A.; Joubert, Y.; Lheritier, K.; Speziale, A.; Junge, G.; Gregson, J.; De Benedetti, F. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0492 Long-Term Safety and Efficacy of Canakinumab in Patients with Caps: Final Results from The Beta-Confident Registry. (15th July 2016) Authors: Kuemmerle-Deschner, J.B.; Hoffman, H.; Hawkins, P.N.; van der Poll, T.; Walker, U.A.; Speziale, A.; Tilson, H.H.; Joubert, Y. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0532 Efficacy and Safety of Canakinumab in Patients with Active Recurrent or Chronic TNF-Receptor Associated Periodic Syndrome (TRAPS). (9th June 2015) Authors: Lachmann, H.; Cattalini, M.; Obici, L.; Barcellona, R.; Speziale, A.; Joubert, Y.; Junge, G.; Gattorno, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 852 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0554 Final Analysis of Study of Efficacy and Safety of Canakinumab in Active Hyper-IGD Syndrome. (9th June 2015) Authors: Arόstegui, J.I.; Anton, J.; Calvo, I.; Robles, A.; Speziale, A.; Joubert, Y.; Junge, G.; Yagüe, J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0569 Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes (Colchicine Resistant FMF, HIDS/MKD and TRAPS). (15th July 2016) Authors: De Benedetti, F.; Anton, J.; Gattorno, M.; Lachmann, H.; Kone-Paut, I.; Ozen, S.; Frenkel, J.; Simon, A.; Zeft, A.; Ben-Chetrit, E.; Hoffman, H.; Joubert, Y.; Lheritier, K.; Speziale, A.; Junge, G.; Xu, X. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗